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Conspiracy Theory: Minireview
RAS and RAF Do Not Act Alone
Several recent papers have added new proteins that
conspire with RAS, RAF, and receptors to transduce
signals. These new findings raise many more questions
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California Institute of Technology than they answer and suggest that we need to reevaluate
RAS and RAF signaling and its regulation.Pasadena, California 91125
SUR-8/SOC-2 Helps RAS
EGF receptor signaling in C. elegans has been most
extensively analyzed in the context of vulval develop-Introduction
ment, which provides a facile assay for RAS activity.In the early 1990s, genetic analysis in D. melanogaster
Mutants of RAF, MEK, MAP kinase, and KSR-1 suppressand C. elegans helped define a signaling pathway from
the effects of activated RAS in C. elegans. Recently, acell surface receptors to the nucleus. Cell surface recep-
new protein, SUR-8 (Suppressor of RAS), was identifiedtors with intrinsic tyrosine kinase activity (receptor tyro-
in this way (Sieburth et al., 1998). This protein was alsosine kinases or RTKs) respond to peptide ligands,
identified as acting downstream of the C. elegans FGFR,growth factors, and inductive signals in development.
which when constitutively active leads to a phenotypeActivation of RTKs often leads to activation of RAS,
called Clear (hence soc-2, Suppressor of clear; Selforswhich in its GTP-bound state activates effectors, the
et al., 1998). Mutants of SEM-5 or SOC-2 disrupt sig-proteins that exert its biological effect. The identification
naling by activated FGFR. Because SUR-8/SOC-2 isof SOS (Son of sevenless) as a guanine nucleotide ex-
necessary for the action of activated FGFR and of RAS,change factor for RAS, and the adaptor protein GRB2
SUR-8/SOC-2 is likely to be a positive regulator in RAS(in mammals)/SEM-5 (in C. elegans)/DRK (in Drosophila),
signaling.coupled with the finding that these two proteins act
SUR-8/SOC-2 and a human homolog have 18 leucine-downstream of RTKs and upstream of RAS, allowed
rich repeats (LRRs), a relatively common protein±proteinthe biochemical linking of RTKs to RAS activation. The
interaction motif (Kobe and Deisenhofer, 1994) and oneadaptor GRB2 binds to proteins phosphorylated on tyro-
that is found in adenylyl cyclase, an effector for S. cere-sine by RTKs and thereby recruits SOS to the membrane,
visiae RAS. Indeed, SUR-8/SOC-2 binds to RAS but notallowing it to activate RAS. Similarly, the finding that the
RAF, MEK, MAPK, or KSR-1 by yeast two-hybrid assays.serine/threonine protein kinase RAF acts downstream
In vitro, SUR-8/SOC-2 binds the effector domain of RAS.of RAS led to its identification as a bona fide effector
for RAS. Activation of RAS results in the recruitment of
RAF to the plasma membrane where it is activated by
a not-well-defined mechanism that involves lipid second
messengers and phosphorylation (Campbell et al., 1998;
Rommel and Hafen, 1998).
The genetic results that led to the definition of this
major tyrosine kinase±RAS signaling pathway were the
identification of genes with similar or identical mutant
phenotypes, and the ordering of those genes into a linear
pathway using double mutant analysis. For example,
activated RAS bypassed the requirement for the recep-
tor tyrosine kinase, and inactive RAS blocked signaling
by an activated receptor. Thus, RAS was inferred to be
a downstream target of signaling by the receptors such
as EGF receptor (EGFR) and FGF receptor (FGFR). Simi-
larly, RAF, MEK (MAP/ERK kinase), and MAP (mitogen-
activated protein) kinase (together constituting one ver-
sion of a MAP kinase cascade) are required for signaling
by activated RAS, and GRB2 and SOS are necessary to
couple the activated receptor to RAS.
While these proteins would apparently be sufficient
for signaling from the surface to the nucleus, over the
last few years new components have been added con-
tinually, gradually burdening the simple view of this
broadly used signaling pathway (Figure 1). For example,
KSR (Kinase suppressor of RAS, a RAF-like serine/thre-
Figure 1. Model of SUR-8/SOC-2 and CNK in RTK to MAP Kinase
onine protein kinase) and 14-3-3 (an abundant cyto- Signaling
plasmic protein named after a spot on a two-dimen-
A generic pathway of signal transduction from a receptor tyrosine
sional protein gel) have recently been shown to stimulate kinase to MAP kinase. Arrows indicate catalysis: GDP release in the
RAF activation (reviewed by Rommel and Hafen, 1998; case of SOS; phosphorylation in the cases of RTK, RAF, MEK, and
MAP kinase.Campbell et al., 1998).
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A RAS effector loop mutant that fails to bind RAF none- worm homologs. These domains include a sterile alpha
motif (SAM) domain, a PDZ domain, two proline-richtheless binds SUR-8, whereas an effector loop mutant
(P34G) that fails to bind SUR-8/SOC-2 nonetheless (potential SH3-binding) domains, and a pleckstrin ho-
mology (PH) domain; such domains are found in manybinds RAF. Thus, SUR-8 could be another effector of
RAS or could regulate the ability of RAS to interact with proteins involved in signaling and suggest further inter-
actions of CNK with other proteins and small molecules.effectors. SUR-8/SOC-2 is not tyrosine phosphorylated
in response to FGF under conditions in which the adap- CNK interacts with RAF: RAF coimmunoprecipitates
with CNK but SEV does not. In two-hybrid assays intor protein FRS2 (FGF-receptor substrate 2) is phos-
phorylated (Selfors et al., 1998), suggesting that SUR- yeast, a C-terminal portion of CNK that contains the PH
domain interacts with the RAF kinase domain. Thus, the8/SOC-2 is not acting as an adaptor protein for SH2
domains. SAM, PDZ, and novel domains might be available for
other interactions, although it is not known whether CNKThe structure of one LRR protein, ribonuclease inhibi-
tor, suggests that this class of protein can bind multiple also binds other proteins in the RAS-RAF signaling path-
way. Also, CNK localizes to regions of cell contact,other proteins (Kobe and Deisenhofer, 1994). Two sur-
8/soc-2 mutations picked for their effect on EGFR signal- suggesting a potential subcellular localization function
(Therrien et al., 1998). The relationship between this pro-ing are in the seventh and fifteenth leucine-rich repeats
whereas two mutations picked for their effects on FGFR posed function of CNK and the function of the LIN-2,
-7,-10 complex that localizes C. elegans EGFR and othersignaling are in the third and seventeenth LRRs (Sieburth
et al., 1998, Selfors et al., 1998). SUR-8/SOC-2 with a receptors (Bredt, 1998) is unclear.
DOF (Downstream of FGFR) Helps FGFRmutation in repeat 7 is defective not only in its function
in vivo but also in its ability to bind to RAS; however, FGFR signaling in Drosophila has been best character-
ized in tracheal morphogenesis. The DOF protein (Down-there is no evidence yet that this is specific to interaction
with RAS (Sieburth et al., 1998). These observations stream of FGFR) was identified because, when mutated,
it leads to developmental defects similar to those inraise the question of whether portions of SUR-8/SOC-2
are specific to either the EGFR or the FGFR signaling flies with mutations in the two Drosophila FGFR genes
(Vincent et al., 1998). DOF mutants are defective in func-pathway. Addressing this issue will require a more sys-
tematic study of the LRRs as well as testing whether all tions of both FGFRs but do not affect EGFR or SEV
signaling. DOF protein is localized to the cytoplasm andfour mutations affect FGFR and EGFR signaling.
Whereas inactivation of either SUR-8/SOC-2 or KSR-1 cell periphery (Vincent et al., 1998). DOF has two poten-
tial protein±protein interaction motifs, a coiled coil do-has only minor effects on vulval development, inactiva-
tion of both proteins blocks signaling; thus, they are main and an ankyrin domain, as well as many tyrosines
embedded in consensus motifs for binding the usualpartially redundant for RAS signaling (Sieburth et al.,
1998). By double mutant analysis, KSR-1 and SUR-8/ cast of RTK effectors such as GRB2. Activated RAS or
RAF partly suppress loss-of-function mutations of DOF,SOC-2 act upstream of or in parallel to RAF: a gain-of-
function RAF mutation bypasses the requirement for consistent with DOF acting upstream of RAS.
One way in which the FGFR couples to RAS activation,either single protein. Whether activated RAF bypasses
the need for both proteins is an open question, as is at least in vertebrates, is via the membrane-localized
adaptor FRS2, which is phosphorylated and then re-whether these proteins are involved in RAF activation,
localization, or function. cruits GRB2´SOS (Kouhara et al., 1997). Similarly, DOS
(Daughter of sevenless), which acts in RTK-mediatedCNK Helps RAF
The fly Sevenless (SEV) protein, an RTK specifically in- signaling in Drosophila, has consensus SH2-binding
sites and thus might serve to recruit GRB2. DOS is avolved in photoreceptor specialization, signals via DRK,
SOS, RAS, RAF, MEK, and MAP kinase. Using a now- substrate for the phosphatase CSW/SHP-2/PTP-2, which
acts positively in signaling (Herbst et al., 1996; Gutchstandard powerful screen for eye development defects,
Therrien et al. (1998) identified the Connector enhancer et al., 1998). DOF might be analogous to FRS2 and other
similar adaptors (Figure 2). The role of DOF as an adaptorof KSR (CNK) protein as an enhancer of a dominant-
negative KSR mutant. Mutation of CNK suppresses the protein specific for a single kind of receptor in a cell
also has parallels in T cells, where the recently clonedphenotype of activated RAS or SEV but not RAF, sug-
gesting that it acts upstream of RAF. CNK mutations adaptor protein LAT (Linker for activation of T cells) may
play a similar role. LAT is palmitoylated on C-terminalaffect developmental processes associated with recep-
tors other than SEV, such as EGFR, and thus might cysteines, and this palmitoylation is required for its func-
tion, perhaps to localize it in sphingolipid rafts in thealso act in these pathways. Moreover, CNK is tyrosine
phosphorylated in response to EGF in mammalian cells. membrane (Zhang et al., 1998). DOF might be localized
to the cell periphery by interactions with other proteins,Overexpression of a wild-type CNK results in apparently
contradictory affects: it slightly inhibits signaling in an or even via modification of its C-terminal cysteines.
These proteins may differ in their membrane localizationotherwise wild-type background, enhances an active
RAS phenotype, but suppresses an activated RAF phe- strategies, since FRS2 is myristoylated, LAT is palmitoy-
lated, and DOS has a PH domain. Such differences mightnotype. These observations suggest that CNK interacts
with regulators or targets of RAS and RAF, and that the contribute to their specificity for receptor tyrosine ki-
nases. We speculate that such SH2-binding platformsstoichiometry of CNK to RAS, RAF, or other interacting
proteins is important for signaling. (FRS2, DOS, LAT, and DOF) might recruit both positively
and negatively acting proteins and their phosphorylationCNK has several protein interaction domains in addi-
tion to a novel domain defined by the fly, human, and state would thus be crucial to the level of signaling
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Figure 2. Different Types of RTK Adaptors
Receptor tyrosine kinases are known to re-
cruit GRB2´SOS in three ways: receptor auto-
phosphorylation and binding of GRB2´SOS;
via an intermediate adaptor such as Shc,
which binds GRB2´SOS once it is recruited
to the RTK; or phosphorylation of membrane-
localized proteins such as FRS-2, LAT, and
possibly DOF.
necessary for appropriate function of each particular molecular interactions (Bourne et al., 1990). Since most
receptor in each cell type. of the proteins we have considered in this review
Conclusions (CNK, KSR, SUR-8/SOC-2) have been isolated in genetic
New proteins identified genetically are guaranteed to screens that rely on the activity of the MAPK cascade,
have an observable function in vivo. One challenge is to it is possible that other subsets of adaptors/scaffolding
comprehend the biochemical function of such proteins, proteins exist that favor activation of different effector
and also to incorporate into functional models those pathways downstream of RAS. There is also an addi-
proteins defined by in vitro properties such as binding tional level of complexity in mammalian cells due to
other known proteins. The recent results extend this the existence of different RAS isoforms that might have
challenge. For example, CNK and SUR-8/SOC-2 share different functional characteristics. Similarly, there are
genetic properties. Both proteins act in multiple receptor different isoforms of RAF, MEK, and MAPK, and the
pathways utilizing RAS and RAF, and both act down- functional differences among them are not well under-
stream of RAS and upstream of RAF based on double stood yet, although the recent identification of scaffold-
mutant studies. Yet the data so far indicate that SUR- ing proteins (MP-1) that selectively couple MEK-1 to
8/SOC-2 binds RAS while CNK binds RAF. C. elegans MAPK-1 (Schaeffer et al., 1998) suggests that such dif-
has a protein that is similar to CNK but it has not been ferences exist and may be relevant. Specific interactions
characterized. These two proteins join two other types could be favored by the general localization mechanism
of proteins, 14-3-3 proteins and KSR, found as modi- just discussed, or by the existence of different preas-
fiers of the RAS/MAPK cascade, that also seem to act sembled transduction machines, whose recruitment to
downstream of RAS and upstream or parallel to RAF. the activated RAS would depend on a balance among
What are they all doing? One approach to understand- some different adaptor/scaffolding proteins. Changes
ing their function is to consider some of the major un- in these proteins would therefore bias the effector path-
solved questions about RAS. For example, what controls ways recruited by RAS in different cells or at different
which RAS effectors become activated? What deter- stages of differentiation.
mines the dynamic properties of signaling cascades ac- What confers particular signaling properties to RAS
tivated by RAS? and RAF once they are activated? Changes in the dy-
In C. elegans vulva development or D. melanogaster namics of signaling in a RAS-MAPK pathway can result
R7 photoreceptor differentiation, RAS functions can be in different cellular outcomes (reviewed in Marshall,
genetically rescued by activated RAF, MEK, or MAPK, 1995), and activation of MAPK by RTKs can display
but in mammalian systems such as cell transformation nonlinear signaling properties in some systems (for ex-
and IL-2 production in T cells, RAS function requires ample, see Huang and Ferrell, 1996). One possible role
activation of more than a single downstream effector for some of the proteins we have discussed could be
(Campbell et al., 1998). GTP-bound RAS can interact to affect the duration and intensity of signaling in the
with many different effectors, but little is known about cell, by stabilizing interactions among the different com-
the mechanisms that control which ones are activated ponents, for example, or by controlling when the signal-
in a defined cell type in response to different stimuli, or ing is terminated.
how partially redundant effectors transduce the RAS
Study of the new proteins discussed here may well
signal. What specifies which RAS effector is used? Is it
change our view of how RAS and RAF function and help
more like a cocktail party in which the signaling players
answer these basic questions posed by the complexityare constrained to a region and thus have an increased
of signal transduction mechanisms.probability of interaction, as the concentration of signal-
ing molecules in sphingolipid rafts suggests (reviewed
in Anderson, 1998)? Or, is it like a formal dinner with Selected Reading
assigned seating guaranteeing particular interactions?
Anderson, R.G.W. (1998). Annu. Rev. Biochem. 67, 199±225.Along these lines, does a certain domain, such as the
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125±132.act, utilizing the energy of GTP hydrolysis to govern
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